Sign inGet started

Monnet Dominique

Insider CIK 1632798 · PDLI President and CEO · ALXN SVP, Chief Marketing Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PDLI PDL BIOPHARMA, INC. S Sale2020-12-162020-12-17500,000$2.60 $1.30M734,921SEC↗
PDLI PDL BIOPHARMA, INC. F Tax w/h2020-02-072020-04-07672,505$3.51 $2.36M1,234,921SEC↗
PDLI PDL BIOPHARMA, INC. A Award2020-01-082020-04-071,233,766— $01,907,426SEC↗
PDLI PDL BIOPHARMA, INC. A Award2020-01-082020-01-101,233,766— $01,907,426SEC↗
PDLI PDL BIOPHARMA, INC. A Award deriv2019-03-282019-04-012,450,000— $02,450,000SEC↗
PDLI PDL BIOPHARMA, INC. A Award deriv2019-03-282019-04-162,450,000— $02,450,000SEC↗
PDLI PDL BIOPHARMA, INC. A Award2019-03-282019-04-01431,317$3.72 $1.60M653,902SEC↗
PDLI PDL BIOPHARMA, INC. A Award2019-03-282019-04-16451,075$3.72 $1.68M673,660SEC↗
PDLI PDL BIOPHARMA, INC. F Tax w/h2018-12-272018-12-2817,615$3.02 $53.2K222,585SEC↗
PDLI PDL BIOPHARMA, INC. A Award deriv2018-09-252018-09-271,479,944— $01,479,944SEC↗
PDLI PDL BIOPHARMA, INC. A Award2017-09-122017-09-13240,200— $0240,200SEC↗
PDLI PDL BIOPHARMA, INC. A Award deriv2017-09-112017-09-13961,000— $0961,000SEC↗
ALXN ALEXION PHARMACEUTICALS IN S Sale2015-05-202015-05-22256$162.40 $41.6K8,787SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award deriv2015-02-272015-03-0318,300— $018,300SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2015-02-272015-03-033,830— $09,043SEC↗
ALXN ALEXION PHARMACEUTICALS IN S Sale2015-02-102015-02-12325$171.15 $55.6K5,213SEC↗
ALXN ALEXION PHARMACEUTICALS IN A Award2015-02-052015-02-092,538— $05,538SEC↗